Genetic counseling, virtual visits, and equity in the era of COVID-19 and beyond
- PMID: 34291525
- PMCID: PMC8426877
- DOI: 10.1002/jgc4.1469
Genetic counseling, virtual visits, and equity in the era of COVID-19 and beyond
Abstract
Overnight, as a result of the COVID-19 pandemic, telehealth rapidly transitioned from limited application to widespread implementation. The field of genetic counseling was well positioned to make this transition to virtual care since there is generally less of a need for patients to be seen in-person for physical exams or urgent care. Going forward, virtual visits will presumably become a mainstay in the provision of genetic services and it is anticipated that clinics will adopt "hybrid" models with both in-person and virtual visit options. This commentary highlights the successes and challenges in the rapid implementation of virtual visits, focusing on who has benefited versus who has been challenged or left behind. We also discuss genetic testing considerations, including the additional steps required for patients and clinicians when testing is ordered outside of the clinical setting, which can result in delays or a lack of testing altogether. Future research considerations are presented to address the needs among the most vulnerable and help ensure equitable access and benefit.
Keywords: COVID-19; disparities; genetic counseling; genetic testing; telegenetics; telehealth; virtual visits.
© 2021 National Society of Genetic Counselors.
Conflict of interest statement
Wendy Uhlmann receives book royalties from Wiley‐Blackwell: John Wiley & Sons, Inc. Andrew McKeon and Catharine Wang declare that they have no conflict of interest.
Figures
References
-
- Ahimaz, P., Giordano, J., Disco, M., Harrington, E., Levinson, E., Spiegel, E., Andrews, C., Griffin, E., Hernan, R., & Wynn, J. (2021). COVID contingencies: Early epicenter experiences of different genetics clinics at a New York City institution inform emergency adaptation strategies. Journal of Genetic Counseling. 1–11. 10.1002/jgc4.1409. in press. - DOI - PMC - PubMed
-
- Bergstrom, K. L., Brander, T. E., Breen, K. E., & Naik, H. (2021). Experiences from the epicenter: Professional impact of the COVID‐19 pandemic on genetic counselors in New York. American Journal of Medical Genetics Part C Seminars in Medical Genetics, 187(1), 28–36. 10.1002/ajmg.c.31855 - DOI - PMC - PubMed
-
- Bradbury, A. R., Patrick‐Miller, L. J., Egleston, B. L., Hall, M. J., Domchek, S. M., Daly, M. B., Ganschow, P., Grana, G., Olopade, O. I., Fetzer, D., Brandt, A., Chambers, R., Clark, D. F., Forman, A., Gaber, R., Gulden, C., Horte, J., Long, J. M., Lucas, T., … Yao, X. (. S. (2018). Randomized noninferiority trial of telephone vs in‐person disclosure of germline cancer genetic test results. Journal of the National Cancer Institute, 110(9), 985–993. 10.1093/jnci/djy015 - DOI - PMC - PubMed
-
- Buchanan, A. H., Datta, S. K., Skinner, C. S., Hollowell, G. P., Beresford, H. F., Freeland, T., Rogers, B., Boling, J., Marcom, P. K., & Adams, M. B. (2015). Randomized trial of telegenetics vs. in‐person cancer genetic counseling: Cost, patient satisfaction and attendance. Journal of Genetic Counseling, 24(6), 961–970. 10.1007/s10897-015-9836-6 - DOI - PMC - PubMed
